When peripheral CD8+ T lymphocytes were assessed in metastatic breast cancer patients during the post-salvage taxane chemotherapy follow-up, it was found that CD8+CD28− populations were increased in breast cancer patients compared to the control cohort [23]. The gene discussed is CD8A; the disease is breast cancer.